Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-075-7 | CAS number: 91-53-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Peer-reviewed assessment report (attached in section 13)
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- not applicable
- GLP compliance:
- yes
- Remarks:
- self-certified to US EPA regulations [40 CFR Part 160]; and OECD regulations [ENV/MC/CHEM (98) 17]
- Type of assay:
- other: mammalian cell cytogenicity test
Test material
- Reference substance name:
- Ethoxyquin
- EC Number:
- 202-075-7
- EC Name:
- Ethoxyquin
- Cas Number:
- 91-53-2
- Molecular formula:
- C14H19NO
- IUPAC Name:
- ethoxyquin
- Details on test material:
- Chemical name
IUPAC: 6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline
CAS: 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Crl:CD-1®(ICR)BR mouse
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Concentration of test material in vehicle: 37.5, 75, or 150 mg/ml
- Amount of vehicle (if gavage or dermal): 10 ml/kg - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test article was formulated in corn oil. - Duration of treatment / exposure:
- Single gavage, up to 48h post-exposure
- Frequency of treatment:
- once
- Post exposure period:
- 24h or 48 h
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 375 mg/kg bw/day (nominal)
- Dose / conc.:
- 750 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 500 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 6 males (all doses, 24h, or 0 and 1500 mg/kg, 48h)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
- Route of administration: oral
- Doses / concentrations: 80 mg(kg
Examinations
- Tissues and cell types examined:
- bone marrow, polychromatic erythrocytes (PCEs) / normochromatic erythrocytes (NCEs)
- Details of tissue and slide preparation:
- Bone marrow was extracted.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
Maximum tolerated dose was estimated to be 1,500 mg/kg bw.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): Ethoxyquin did not induce statistically significant increases in micronucleated PCEs at any test article dose examined (375, 750 and 1,500 mg/kg bw)
- Ratio of PCE/NCE (for Micronucleus assay): Ethoxyquin was not cytotoxic to the bone marrow (i.e., no statistically significant decreases in the PCE:NCE ratios) at any dose of the test article.
Any other information on results incl. tables
Findings:
The test article, ethoxyquin, induced mortality in three 1,500 mg/kg bw animals and signs of clinical toxicity in the treated animals at 750 and 1,500 mg/kg bw. The clinical signs of toxicity included hypoactivity, squinted eyes, irregular respiration, ataxia, and/or a temporary trace (standing on hind limbs with head in upright position and little movement). Ethoxyquin did not induce statistically significant increases in micronucleated PCEs at any test article dose examined (375, 750 and 1,500 mg/kg bw). Additionally, ethoxyquin was not cytotoxic to the bone marrow (i.e., no statistically significant decreases in the PCE:NCE ratios) at any dose of the test article.
The positive control substance, cyclophosphamide, gave the expected increase in the percentage of micronucleated polychromatic erythrocytes.
Table Summary of results in the micronucleus assay
Treatment |
Dose |
Harvest time |
% Micronucleated PCEs Mean of 2,000 per animal (males) |
Ratio PCE:NCE Mean (males) |
Vehicle control |
Corn oil 10 mL/kg |
24 hr |
0.04 ± 0.01 |
0.69 ± 0.02 |
48 hr |
0.02 ± 0.01 |
0.69 ± 0.04 |
||
Positive control |
Cyclophosphamide 80 mg/kg bw |
24 hr |
1.60 ± 0.08* |
0.60 ± 0.04 |
Ethoxyquin |
375 mg/kg bw |
24 hr |
0.05 ± 0.02 |
0.72 ± 0.10 |
750 mg/kg bw |
24 hr |
0.03 ± 0.02 |
0.58 ± 0.07 |
|
1,500 mg/kg bw |
24 hr |
0.03 ± 0.02 |
0.56 ± 0.05 |
|
48 hr |
0.02 ± 0.01 |
0.54 ± 0.08 |
Notes: * Significant greater than the corresponding vehicle control, p < 0.01
Applicant's summary and conclusion
- Conclusions:
- As information was provided via a peer-reviewed assessment report, it can be considered as sufficiently reliable to assess the potential of ethoxyquin for the induction of micronuclei in mammalian cells, i.e. in the bone marrow in mice in vivo.
Ethoxyquin proved negative in the mouse bone marrow micronucleus assay under the conditions of this study up to the highest dose level of 1500 mg/kg bw that was already toxic to the animals. So it can be concluded that the positive result of the available chromosome aberration test in vitro has no relevance in the living organism, and can hence be neglected. - Executive summary:
In the Crl:CD-1®(ICR)BR mouse bone marrow micronucleus assay (OECD 474), six males per dose were treated orally by gavage with ethoxyquin at doses of 0, 375, 750 or 1500 mg/kg bw. Bone marrow cells were harvested at 24h or 48h post-treatment. The vehicle was corn oil.
There were signs of toxicity (hypoactivity, squinted eyes, irregular respiration, ataxia, and/or a temporary trace (standing on hind limbs with head in upright position and little movement)) during the study. Ethoxyquin was tested at an adequate dose based on toxicity. The positive control induced the appropriate response. There was not a significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 474 for in vivo cytogenetic mutagenicity data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
